Staging and identification of risk groups in pediatric germ cell ovarian tumors

Cover Page

Cite item

Full Text

Abstract

Data on the staging and identification of the risk groups in pediatric germ cell ovarian tumors are presented in the review of the literature. Both staging and risk group identification are significantly different from accepted for adult patients.

About the authors

Innesa Viktorovna Nechushkina

N.N.Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation; Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation

Email: ivnechushkina@mail.ru
MD, Ph.D, Professor, pediatric oncologist, obstetrician-gynecologist in the Department of Surgery No.2 23, Kashirskoe h., Moscow, 115478, Russian Federation

Valentina M Nechushkina

N.N.Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation; N.I.Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation

Email: drnechushkina@mail.ru
MD, Ph.D, Leading Researcher in the Department of Combined and Radiotherapy Treatment Approaches of Treatment of Oncoginecological Diseases in the Research Institute of Clinical Oncology, Professor in the Department of Oncology and Radiotherapy 23, Kashirskoe h., Moscow, 115478, Russian Federation

Elena I Boychenko

N.N.Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation; Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation

Email: e.i.boychenko@yandex.ru
Cand. Sci. (Med.), Associate Professor, Pediatric Oncologist in the Department of Surgery No.2 in the Research Institute of Pediatric Oncology and Hematology, Associate Professor in the Department of Pediatric Oncology 23, Kashirskoe h., Moscow, 115478, Russian Federation

Natal'ia A Susuleva

N.N.Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation; Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation

Email: susuleva@mail.ru
MD, Ph.D, Pediatric Oncologist in the Department of Chemotherapy in the Research Institute of Pediatric Oncology and Hematology, Professor in the Department of Pediatric Oncology 23, Kashirskoe h., Moscow, 115478, Russian Federation

Anatolii P Kazantsev

N.N.Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation

Email: oncoanat@mail.ru
MD, Ph.D, Head of the Department of Surgery No.2 in the Research Institute of Pediatric Oncology and Hematology 23, Kashirskoe h., Moscow, 115478, Russian Federation

Polad A Kerimov

N.N.Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation

Email: polad73@mail.ru
MD, Ph.D, Leading Researcher in the Department of Surgery No.2 in the Research Institute of Pediatric Oncology and Hematology 23, Kashirskoe h., Moscow, 115478, Russian Federation

Mikhail I Nechushkin

N.N.Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation

MD, Ph.D, Professor, Leading Researcher in the Department of radiosurgery in the Research Institute of Clinical Oncology 23, Kashirskoe h., Moscow, 115478, Russian Federation

Mikhail A Rubansky

N.N.Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation

Email: ubansky@yandex.ru
Cand. Sci. (Med.), Pediatric Oncologist in the Department of Surgery No.2 in the Research Institute of Pediatric Oncology and Hematology 23, Kashirskoe h., Moscow, 115478, Russian Federation

References

  1. Palenzuela G, Martin E, Meunier A et al. Comprehensive staging allows for excellent out-come in patients with localized malignant germ cell tumor ovary. Ann Surg 2008; 248: 836-41.
  2. Liu Q, Ding X, Yang J et al. The signification of comprehensive staging surgery in malignant ovarian germ cell tumors. Gynecol Oncol 2013; 131 (3): 551-4.
  3. Billmire D.F, Cullen J.W, Frederick J.R et al. Surveillance after initial surgery for pediatric and adolescent girls with stage I ovarian germ cell tumors: report from the Chidren’s Oncology Group. J Clin Oncol 2014; 32 (5): 465-70.
  4. Billmire D, Vinocur C, Rescorla F et al. Outcome and staging evaluation in malignant germ cell tumors of the ovary in children and adolescents: an intergroup study. J Pediatr Surg 2004; 39 (3): 424-9.
  5. Kurman R.J, Norris H.J. Endodermal sinus tumor of ovary. A clinical and pathologic analysis of 71 cases. Cancer 1976; 38 (6): 2404-19.
  6. Cushing B, Giller R, Cullen J.W et al. Randomized comparison of combination chemotherapy with etoposide, bleomycin and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study - Pediatric Oncology Group 9049 and Children Cancer Group 8882. J Clin Oncol 2004; 22: 2691-700.
  7. Palenzuela G, Martin E, Meunier A et al. Comprehensive staging allows for excellent out-come in patients with localized malignant germ cell tumor ovary. Ann Surg 2008; 248: 836-41.
  8. Буланов А.А., Трякин А.А., Тюляндин С.А. Лечение герминогенных опухолей ранних (I, IIA, B) стадий. Практическая онкология. 2006; 7 (1): 24-9.
  9. Тюляндин С.А. Герминогенные опухоли яичников. Практическая онкология. 2006; 7 (1): 52-61.
  10. Oltmann S.C, Garcia N.M, Barber R et al. Pediatric ovarian malignancies: how efficacious are current staging practices? J Pediatr Surg 2010; 45 (6): 1096-102.
  11. Frazier A.L, Rumcheva P, Olson T et al. Application of the adult international germ cell classification system to pediatric malignant non-seminomatous germ cell tumors: a report from the Children’s Oncology Group. Pediatr Blood Cancer 2008; 50 (4): 746-51.
  12. Lee K.H, Lee I.H, Kim B.G et al. Clinicopathologic characteristics of malignant germ cell tumors in the ovaries of Korean women; A Korean Gynecologic Oncology Group Study. Int J Gynecol Cancer 2009; 19 (1): 84-7.
  13. Zanagnolo V, Sartori E, Galleri G et al. Clinical review of 55 cases of malignant ovarian germ cell tumors. Eur J Gynaecol Oncol 2004; 25 (3): 315-20.
  14. Panteli C, Curry J, Kiely E et al. Ovarian germ cell tumors: a 17-year study in a single unit. Eur J Pediatr Surg 2009; 19: 96-100.

Copyright (c) 2019 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies